Home
PharmaCann

PharmaCann Market Share Analysis for August 2026

CHICAGO--(BUSINESS WIRE)-- PharmaCann Inc. (“PharmaCann” or the “Company”), one of the largest, private, vertically integrated cannabis companies in the United States, today announced that it has completed an additional issuance of 12% Senior Secured Notes due June 30, 2025 (the “Notes”). The net pr

Finance > Investing

Domainpharmacann.com

Year Founded2014

Employees51 - 200

Annual Revenue$200M - $500M

PharmaCann

PharmaCann (including company regionals)

pharmacann.com

See more website traffic and engagement information

PharmaCann Revenue up to August 2026 is 200M - 500M

revenue generated by PharmaCann top domains

PharmaCann top domains revenue over 3 years

Revenue for PharmaCann top domains

pharmacann.com200M - 500M

See more with Sales Intelligence

Total visits to PharmaCann's top domains

Understand PharmaCann market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

pharmacann.com10K

See more with Sales Intelligence

Avg. visit duration in PharmaCann's top domains

Analyze PharmaCann engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

pharmacann.com00:01:38

See more with Sales Intelligence

Avg. pageviews on PharmaCann's top domains

See how PharmaCann keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

pharmacann.com2.23

See more with Sales Intelligence

PharmaCann top competitors by domain

Top similar sites in August 2026, ranked by their affinity

camdispensary.comCompany NameCalifornia Artisanal MedicineEmployees51 - 200HQUnited States, Colorado, DenverAnnual revenue$1M - $2MTotal visits8.1KN/A

Top technologies used by PharmaCann

These are the website technologies, by industry, used by PharmaCann top domains

Conversion & Analytics (5)

Google Analytics

Payment & Currencies (5)

Cart Functionality

Widget (4)

Twemoji

Advertising (3)

Google Adsense

More Technologies

12

See all

News & Signals from PharmaCann

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsCresco Labs acquired PharmaCann, Inc. for $50M on Sep 2nd '26.Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) ("Cresco Labs" or the "Company") today announced the closing of its acquisition of 100% of the outstanding equity interests in PharmaCann Penn, LLC ("PharmaCann") for an aggregate consideration of US$50 million (the "Transaction").

NewsPharmaCann, Inc. sold assets to Grown Rogue International in the amount of $4.5M on Aug 21st '26.Shares of Grown Rogue International Inc. (CSE: GRIN) (OTCQB: GRUSF) are climbing Friday after the company announced the first steps toward acquiring PharmaCann's New York license and assets, including a substantial cultivation and manufacturing facility and four existing Verilife dispensaries.

NewsPharmaCann, Inc. receives financing of $9M.A secured loan provides PharmaCann's New York operation with up to $9 million to restart Hamptonburgh production, replenish retail inventory and meet working capital requirements.